Journal of the American Society of NephrologyGeneticsPeer-reviewed journal article
Ciliary ARL13B drives renal cystogenesis via its GEF activity
Robert E. Van SciveriD, Avery ForsteriD, Leslie M. LewisiD, Tamara CasparyiD
Abstract
BackgroundPolycystic kidney disease (PKD) is the leading genetic cause of renal failure, resulting in the accumulation of fluid filled cysts and gross enlargement of the kidney. Mutations in PKD1 or PKD2, which encode ciliary polycystin proteins, are the most common cause of PKD. These proteins function in a cilia-dependent cyst activation (CDCA) pathway-one that requires cilia for its pro-cystic function-yet the molecular driver(s) of this pathway are unknown. ARL13B is a regulatory GTPase enriched in cilia and links to renal cystogenesis. ARL13B possesses guanine nucleotide exchange factor (GEF) activity for ARL3, another ARL with links to cilia. MethodsWe used two distinct Arl13b mouse alleles to investigate whether ARL13B is a component of the CDCA pathway: Arl13bV358A encodes for enzymatically normal ARL13B that is undetectable in cilia, and Arl13bR79Q encodes for cilia-localized ARL13B lacking a residue critical for its ARL3 GEF activity. We used these alleles in a Pkd1-deficient adult mouse model and investigated renal morphology (H&E and cystic index analysis), physiology (blood urea nitrogen measurements), renal fibrosis (picrosirius staining and -smooth muscle actin levels), renal injury (SOX9 immunofluorescent staining and quantification), and Wnt signaling ({beta}-catenin and cyclin D1 protein levels). ResultsWe found that loss of ciliary ARL13B or mutation of a single residue critical for its ARL3 GEF activity suppressed Pkd1-dependent cysts. We observed reductions in kidney size, cystic index, and blood urea nitrogen. We also observed suppression of renal fibrosis, renal injury, and {beta}-catenin and cyclin D1 protein levels. ConclusionsOur results identified a subcellular location and mechanism driving Pkd1-dependent renal cystogenesis. We demonstrated that expression of a critical residue for ARL13Bs GEF activity specifically in cilia is a key mechanism of the CDCA pathway driving renal cystogenesis. Key PointsO_LILoss of ciliary ARL13B suppressed renal cystogenesis in an adult mouse model of polycystic kidney disease (PKD) without ablating cilia C_LIO_LILoss of ciliary ARL13B or mutation of the residue critical for its GEF activity did not affect renal morphology or physiology in an adult induced mouse model C_LIO_LIMutation of a residue critical for ARL13B activation of ARL3 suppressed cystic phenotypes in Pkd1-dependent cysts C_LI
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- top 39%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Ciliary ARL13B inhibits developmental kidney cystogenesis in mouse
Robert E. Van Sciver, Alyssa Bushey Long, … Tamara Caspary·Developmental BiologyPeer-reviewed·May 18, 2023
- Hedgehog signaling is non-cell autonomously activated in the cystic kidney of Arl13b mutant mice
Chia-Ling Hsieh, Stephanie Jerman, Zhaoxia Sun·Human Molecular GeneticsPeer-reviewed·Jul 29, 2022
- Cystin is required for maintaining fibrocystin (FPC) levels and safeguarding proteome integrity in mouse renal epithelial cells A mechanistic connection between the kidney defects in cpk mice and human ARPKDRunning title: Cystin deficiency results in FPC degradation
- Ciliogenesis associated kinase 1 accumulates in its inactive form during polycystic kidney disease progression
Alice S. Serafin, Charlène Coquil, … Vincent J. Guen·bioRxiv·May 14, 2026
- PKD1 and PKD2 mRNA cis-inhibition drives polycystic kidney disease progression
Ronak Lakhia, Harini Ramalingam, … Vishal Patel·Nature CommunicationsPeer-reviewed·Aug 14, 2022
- Nonsense-associated alternative splicing as a putative reno-protective mechanism in Pkhd1cyli/Pkhd1cyli mutant mice
Chaozhe Yang, Naoe Harafuji, … Lisa M. Guay‐Woodford·Journal of Molecular MedicinePeer-reviewed·Aug 16, 2023